Profiles of neuropsychologic function in schizophrenia

被引:9
作者
J. Daniel Ragland
机构
[1] Department of Psychiatry, Brain Behavior Laboratory, Univ. Pennsylvania Sch. of Medicine, Philadelphia, PA 19104, Gates Building
基金
美国国家卫生研究院;
关键词
Schizophrenia; Cognitive Difficulty; Illness Onset; Cognitive Remediation; Nonspecific Factor;
D O I
10.1007/s11920-003-0059-4
中图分类号
学科分类号
摘要
In this article, the author reviews basic neuropsychologic issues in the study of schizophrenia. The first issue is whether cognitive dysfunction reflects a degenerative process or is a core feature of the disorder. Evidence demonstrating that cognitive difficulties are present at illness onset and are not caused by medication, illness progression, or other nonspecific factors is reviewed. The second question is less easily answered and deals with whether cognitive difficulties represent generalized dysfunction or differential deficits in specific neurocognitive domains. One difficulty in answering this question is the heterogeneous nature of the disorder. Clinical and cognitive subtyping approaches to reducing heterogeneity are discussed, with the conclusion that cognitive approaches hold the most promise for understanding subtype differences in neurobiologic substrates. Finally, the relation of cognitive ability to functional outcome is described, and it is explained why there is a resurgent interest in remediation efforts. The article closes with suggestions for future directions. Copyright © 2003 by Current Science Inc.
引用
收藏
页码:299 / 302
页数:3
相关论文
共 36 条
[1]  
Kraepelin E., Dementia Praecox and Paraphrenia, (1925)
[2]  
Saykin A.J., Gur R.C., Gur R.E., Et al., Neuropsychological function in schizophrenia: Selective impairment in memory and learning, Arch. Gen. Psychiatry, 48, pp. 618-624, (1991)
[3]  
Saykin A.J., Shtasel D.L., Gur R.E., Et al., Neuropsychological deficits in neuroleptic naive, first episode schizophrenic patients, Arch. Gen. Psychiatry, 51, pp. 124-131, (1994)
[4]  
Spohn H.E., Strauss M.E., Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia, J. Abnorm. Psychol., 98, pp. 367-380, (1989)
[5]  
Goldberg T.E., Weinberger D.R., Effects of neuroleptic medications on the cognition of patients with schizophrenia: A review of recent studies, J. Clin. Psychiatry, 57, SUPPL., pp. 62-65, (1996)
[6]  
Censits D.M., Ragland J.D., Gur R.C., Gur R.E., Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: A longitudinal study, Schizophr. Res., 24, pp. 289-298, (1997)
[7]  
Harvey P.D., Cognitive impairment in elderly patients with schizophrenia: Age related changes, Int. J. Geriatr. Psychiatry, 16, SUPPL., (2001)
[8]  
Kolb B., Whishaw I.Q., Performance of schizophrenic patients on tests sensitive to left or right frontal, temporal, or parietal function in neurological patients, J. Nerv. Ment. Dis., 171, pp. 435-443, (1983)
[9]  
Chapman L.J., Chapman J.P., The measurement of differential deficits, J. Psychiatry Res., 14, pp. 303-311, (1978)
[10]  
McKay A.P., McKenna P.J., Bentham P., Et al., Semantic memory is impaired in schizophrenia, Biol. Psychiatry, 39, pp. 929-937, (1996)